ASMBR and OARSI Meetings Part 1 on Osteoathritis Imaging
This blog is being written on a flight back from San Diego where I have just attended the OARSI (Osteoarthritis Research Society International) meeting and the ASBMR (American Society of Bone and...
View ArticleBetter Training Yields Quality Medical Imaging in Clinical Trials
Study protocol training is one the highest impact factors to acquire quality medical imaging data in clinical trials. When a multi-year clinical trial receives data from many sites all over the globe,...
View ArticlePioneer of Medical Imaging Ultrasound Ignored by History
There is no doubt that medical imaging ultrasound has it’s origins in the development of naval sonar, used to combat the threat of German submarines in the First World War. The field of acoustics is...
View ArticleClinical Trial Criteria and Eligibility
The adventures of medieval knights have fired our imagination since their first description in books such as Search for the Holy Grail, Sir Gawain and the Green Knight, and Parzifal to name a few. I...
View ArticleA Lesson on Advancements in Medical Imaging Technology from a set of 100...
We live in an age of unprecedented technological development, seemingly unlimited in its possibilities, especially in the area of medical imaging technology and research. Or so my professional journals...
View ArticleOsteoarthritis Imaging Abstract Presented at EULAR 2012
I recently attended the 2012 European League Against Rheumatism (EULAR) Annual Congress of Rheumatology in Berlin where a lot of novel clinical research on osteoarthritis, arthritis, and rheumatism was...
View ArticleInnovations in Medical Imaging Software offer New Trial Capabilities
One of the driving forces in medical imaging is the innovation that is taking place in medical imaging software. I previously wrote about this from the 2010 Radiological Society of North America...
View Article3 Principles of Tumor Behavior and Biology
So just how did James Bond, Moby Dick and the London Natural History Museum teach me about oncology in clinical trials and tumor behavior? Here’s my story. As a child I loved wandering through the...
View ArticleEOS Imaging System is an Emerging New Technology
The innovative EOS imaging system generates an x-ray of the whole body in 3D using a fraction of the radiation dose it would take to do this with conventional radiography or CT scans. This represents...
View ArticleLessons in Medical Image Transfer Security from a Smartphone Crash
I have a relative who absolutely adores my daughter (as anyone with eyes and soul would) and regularly uses his Smartphone to take pictures of her. One evening, while showing off the pictures during a...
View ArticleImaging in Oncology Clinical Trials: Visualizing Cancers for Better Treatment
Seeing biological processes has always been extremely rewarding and has had the greatest impact on my scientific career. As a graduate student, I spent a lot of time at the microscope observing cell...
View ArticleMolecular Imaging Tracers: Alzheimer’s Disease and Beyond
I recently attended the 49th annual Drug Information Association (DIA) conference in Boston and had the good fortune to attend individual sessions as well as explore the exhibition hall. With an...
View ArticleTheranostics: The right therapy for the right patient at the right time
What do you get when you combine a molecular diagnostic agent with a targeted therapeutic? A powerful new tool paving the path to personalized medicine called a Theranostic. The basic architecture of a...
View ArticleA Push to Standardize Molecular Imaging Approaches in Clinical Trials
In 2011, the FDA issued a guidance entitled 'Standards for Clinical Trial Imaging Endpoints,' designed to aid sponsors in the use of imaging endpoints in clinical trials. The guidance focuses on...
View ArticleCardiac Safety Monitoring – Benefits and Risks Assessment and the Regulatory...
Cardiovascular risks associated with drugs across many therapeutic areas have necessitated cardiac safety evaluation during the drug development process. Over the years, defining cardiac risk has...
View ArticleBioClinica Oncology Symposium - May 14th 2013
On Tuesday May 14th, BioClinica will be hosting an all-day complimentary oncology symposium as part of their annual User Conference. The symposium will take place at the Hyatt Regency at Penn’s Landing...
View ArticleClinical Assessment of Rheumatoid Arthritis: Advantage MRI
When designing imaging endpoints for prospective clinical trials in Rheumatoid Arthritis (RA), sponsors often consider the use of Magnetic Resonance Imaging (MRI) for assessment. The utilization of MRI...
View Article5 Things Every Data Manager Should Know When It Comes to Medical Images in...
This week the annual Society for Clinical Data Management (SCDM) conference, the world's largest educational event for clinical data managers and related professionals, will be held in Chicago. I have...
View ArticleBlood Pressure Endpoints for Clinical Trials: Are You Monitoring?
This week, I will be hosting a webinar focused on considerations and best practices for Blood Pressure (BP) monitoring as part of the cardiac safety assessment for compounds in development. The...
View ArticleChinese Course in Drug Development and Regulatory Science (CCDRS)-A Primer
I recently sat down with Dr. Boaz Mendzelevski, BioClinica's Vice President of Cardiology, to talk about an upcoming unique drug discovery course taking place in China this week. Dr. Mendzelevski will...
View Article